This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prasad, A. Articles by Quyyumi, A. A. Search for Related Content PubMed PubMed Citation Articles by Prasad, A. Articles by Quyyumi, A. A.

Anti-ischemic effects of angiotensin- converting enzyme inhibition in hypertension

^a Cardiology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA

View larger version (13K): [in a new window]   Figure 1 Change in ischemic threshold (rate-pressure product [RPP]) and duration of exercise at the onset of 1-mm ST-depression in hypertensive and normotensive patients before (open bars) and after (solid bars) treatment with enalapril.

View larger version (17K): [in a new window]   Figure 2 Change in duration of exercise, workload and ST depression at peak exercise, before (open bars) and after (solid bars) with enalapril. METS = metabolic equivalents.

View larger version (17K): [in a new window]   Figure 3 Change in forearm blood flow and vascular resistance in response to bradykinin before (open circles) and after (solid circles) enalapril therapy in hypertensive and normotensive patients. The p values compare bradykinin responses by analysis of variance.